Eric Pujade-Lauraine
埃里克·普亚德-劳兰
MD, PhD
Professor of Medical Oncology医学肿瘤学教授
👥Biography 个人简介
Internationally recognized leader in ovarian cancer clinical research and past chair of the Gynecologic Cancer InterGroup (GCIG). Has led landmark phase III trials defining platinum-based and PARP inhibitor therapies as standards of care in ovarian cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
GCIG Leadership
Served as chair of the Gynecologic Cancer InterGroup, coordinating global collaborative ovarian cancer trials across more than 20 countries.
PARP Inhibitor Trials
Led the SOLO1 and SOLO2 trials establishing olaparib maintenance as standard of care for BRCA-mutated ovarian cancer patients.
Platinum-Based Chemotherapy
Contributed pivotal data on carboplatin-paclitaxel combinations and bevacizumab incorporation in first-line and recurrent ovarian cancer.
Representative Works 代表性著作
SOLO2/ENGOT-Ov21: olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
The Lancet Oncology (2017)
Established olaparib maintenance benefit in BRCA-mutated platinum-sensitive relapsed ovarian cancer, becoming a global standard.
Bevacizumab in patients with platinum-resistant recurrent ovarian cancer (AURELIA)
Journal of Clinical Oncology (2014)
Defined bevacizumab plus chemotherapy benefit in platinum-resistant ovarian cancer, changing clinical practice.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Bradley J. Monk
University of Arizona / HonorHealth
Kathleen N. Moore
Stephenson Cancer Center, University of Oklahoma
Ana Oaknin
Vall d'Hebron University Hospital
Shannon Neville Westin
The University of Texas MD Anderson Cancer Center
关注 埃里克·普亚德-劳兰 的研究动态
Follow Eric Pujade-Lauraine's research updates
留下邮箱，当我们发布与 Eric Pujade-Lauraine（Université Paris Cité）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment